Financial reports
10-Q
2023 Q2
Quarterly report
7 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
24 Feb 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
28 Feb 22
10-Q
2021 Q3
Quarterly report
8 Nov 21
10-Q
2021 Q2
Quarterly report
9 Aug 21
Current reports
8-K
Termination of a Material Definitive Agreement
26 Sep 23
8-K
Submission of Matters to a Vote of Security Holders
21 Sep 23
8-K
Other Events
12 Sep 23
8-K
Voting and Support Agreement
31 Jul 23
8-K
Biogen to Acquire Reata Pharmaceuticals
28 Jul 23
8-K
Entry into a Material Definitive Agreement
10 Jul 23
8-K
Entry into a Material Definitive Agreement
20 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
7 Jun 23
8-K
Reata Pharmaceuticals, Inc. Announces First Quarter 2023 Financial
10 May 23
8-K
Amendments to Articles of Incorporation or Bylaws
1 Mar 23
Registration and prospectus
15-12G
Securities registration termination
6 Oct 23
POSASR
Automatic shelf registration (post-effective amendment)
26 Sep 23
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Sep 23
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Sep 23
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Sep 23
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Sep 23
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Sep 23
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Sep 23
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Sep 23
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Sep 23
Proxies
DEFA14A
Additional proxy soliciting materials
12 Sep 23
DEFM14A
Proxy related to merger
22 Aug 23
PREM14A
Preliminary proxy related to merger
11 Aug 23
DEFA14A
Additional proxy soliciting materials
31 Jul 23
DEFA14A
Additional proxy soliciting materials
28 Jul 23
DEFA14A
Additional proxy soliciting materials
28 Jul 23
DEFA14A
Additional proxy soliciting materials
28 Jul 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
Other
SEC STAFF
SEC staff action: Order
18 Feb 20
SEC STAFF
SEC staff action: Order
5 Feb 20
CT ORDER
Confidential treatment order
15 Dec 17
EFFECT
Notice of effectiveness
14 Jul 17
CORRESP
Correspondence with SEC
12 Jul 17
CORRESP
Correspondence with SEC
10 Jul 17
UPLOAD
Letter from SEC
6 Jul 17
CT ORDER
Confidential treatment order
26 May 16
EFFECT
Notice of effectiveness
25 May 16
CORRESP
Correspondence with SEC
23 May 16
Ownership